Research Roundup: Different Antibody Responses to COVID-19 and More
The Pharma Data
DECEMBER 31, 2020
Researchers at Stanford Medicine found that COVID-19 antibodies preferentially target different parts of the SARS-CoV-2 virus in mild COVID-19 cases than they do in severe cases. The spike protein binds to the ACE2 receptor on human cells, which allows the virus to enter the cell.
52 
Let's personalize your content